Medtronic
MDT
2,135 hedge funds and large institutions have $85.4B invested in Medtronic in 2024 Q4 according to their latest regulatory filings, with 245 funds opening new positions, 795 increasing their positions, 892 reducing their positions, and 153 closing their positions.
60% more first-time investments, than exits
New positions opened: 245 | Existing positions closed: 153
46% more capital inflows, than outflows
Capital inflows: $7.06B | Capital outflows: $4.84B
3% more funds holding
Funds holding: 2,074 → 2,135 (+61)
1.26% more ownership
Funds ownership: 82.04% → 83.29% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 31 → 31 (0)
7% less call options, than puts
Call options by funds: $586M | Put options by funds: $632M
11% less repeat investments, than reductions
Existing positions increased: 795 | Existing positions reduced: 892
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
+$409M |
| 2 |
JP Morgan Chase
New York
|
+$319M |
| 3 |
BlackRock
New York
|
+$252M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$227M |
| 5 |
VanEck Associates
New York
|
+$214M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$520M |
| 2 |
Millennium Management
New York
|
-$404M |
| 3 |
Morgan Stanley
New York
|
-$395M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$313M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$248M |
MDT Hedge Fund Activity: Q4 2024 in Review
2,135 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2024, worth a combined $85.4B — down 9.9% from $94.7B a quarter earlier.
Buyers outnumbered sellers: 245 funds opened new MDT positions and 153 closed out — a net gain of 92 holders — while 795 added to existing stakes and 892 trimmed.
The largest buyer was Beutel, Goodman & Co, opening a new position worth an estimated $409M. The largest seller was Wellington Management Group, cutting an estimated $520M.
- 2,135 institutional investors held Medtronic (MDT) as of Q4 2024, up from 2,074 in Q3 2024.
- Funds reported $85.4B of Medtronic stock for Q4 2024, down 9.9% quarter-over-quarter.
- 245 funds opened new Medtronic positions in Q4 2024 and 153 closed out, a net change of +92 holders.
- The largest Medtronic buyer in Q4 2024 was Beutel, Goodman & Co, an estimated $409M added.
- The largest Medtronic seller in Q4 2024 was Wellington Management Group, an estimated $520M sold.
Based on aggregated 13F filings for Q4 2024.